Skip to main content
. 2020 Dec 15;21(24):9558. doi: 10.3390/ijms21249558

Table 1.

Subject demographics.

Gender
(F; M)
HbA1c (%) Diabetes Duration
(Years)
Insulin Treatment (Y; N) Subjects with Glycemic Control
(Y; N)
Age
(Years)
CTRL (N = 7) (4; 3) 3.9 ± 0.9 NA NA NA 66 ± 14
Diabetic (N = 6) (4; 2) 6.6 ± 0.3 5 ± 5 (0; 6) (6; 0) 75 ± 10
NPDR naïve (N = 6) (2; 4) 7 ± 1 19 ± 8 (4; 2) (4; 2) 74 ± 6
NPDR aflibercept (N = 6) (2; 4) 6.9 ± 0.5 20 ± 8 (5; 1) (6; 0) 70 ± 7
PDR naïve (N = 7) (4; 3) 7.3 ± 0.6 21 ± 6 (7; 0) (2; 5) 70 ± 7
PDR aflibercept (N = 6) (3; 3) 7 ± 1 18 ± 9 (3; 3) (4; 2) 67 ± 8

F = females, M = males. Y = yes, N = no.